Evidence map›Paper›PMID 29400081›Full record

ArticleThe Annals of pharmacotherapy2018

Association of Statin Therapy With Risk of Epilepsy in 2 Propensity Score-Matched Cohorts.

Lakshya U Trivedi, Carlos A Alvarez, Ishak A Mansi

Open access · greenAbstract read
In one paragraph

Article in The Annals of pharmacotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. The Effect of Statins in Epilepsy: A Systematic Review.Journal of neurosciences in rural practice
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Lakshya U Trivedi1 University of Texas Southwestern Medical Center, Dallas, TX, USA.
Carlos A Alvarez2 Texas Tech University Health Sciences Center, Dallas, TX, USA.
Ishak A Mansi1 University of Texas Southwestern Medical Center, Dallas, TX, USA.
Texas Tech University Health Sciences Center · USThe University of Texas Southwestern Medical Center · USVA North Texas Health Care System · US

Funding

UT Southwestern Center of Patient-Centered Outcomes Research (PCOR)R24HS022418 · AHRQ · UT SOUTHWESTERN MEDICAL CENTER · PI HALM, ETHAN A · 2013 to 2017
$5.0M
Safety and Effectiveness of Metformin Therapy in Patients with Type 2 Diabetes anK08DK101602 · NIDDK · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI ALVAREZ, CARLOS A · 2014 to 2017
$536k
AHRQ HHS R24 HS022418NIDDK NIH HHS K08 DK101602
6 · The paper itself

Abstract

backgroundStudies have suggested that statins may have a neuroprotective effect against epilepsy. However, evidence from rat models and case reports have suggested an opposite effect. Overall data are limited.

objectiveTo examine the association between statin use and epilepsy risk in a general population and in a healthy population (individuals with no severe comorbidities).

methodsPatients were Tricare beneficiaries from October 2003 to March 2012. Based on patients' characteristics during baseline phase (fiscal year [FY] 2004-2005), 2 propensity score (PS)-matched cohorts of statin users and nonusers were formed: (1) a PS-matched general cohort and (2) a PS-matched healthy cohort. Our outcome was defined using inpatient or outpatient ICD-9 codes for epilepsy during the follow-up phase (FY 2006 to March 2012) in the cohorts of statin users and nonusers.

resultsThe study included a total of 43 438 patients (13 626 statin users and 29 812 nonusers). The PS-matched general cohort matched 6342 statin users to 6342 nonusers; the odds ratio (OR) of epilepsy in this cohort during follow-up was 0.91; 95% CI = 0.67-1.23. The PS-matched healthy cohort matched 3351 statin users to 3351 nonusers; OR in the PS-matched healthy cohort during follow-up was 1.08; 95% CI = 0.64-1.83.

conclusionsThis study did not demonstrate a significant beneficial or deleterious effect of statin use on risk of being diagnosed with epilepsy. Clinicians should not withhold statins, whenever indicated, in patients with epilepsy.

Indexed as

AdultAgedCohort StudiesComorbidityEpilepsyFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedOdds RatioPropensity ScoreRiskHydroxymethylglutaryl-CoA Reductase Inhibitorsepilepsyneuroprotectionstatins

Identifiers

PMID29400081
PMCPMC6650154
OpenAlexW2588183366

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.